Axsome Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $322.9M | $315.4M | $386.2M | $200.8M | $86.5M | $183.9M | $220.0M | — |
| Accounts Receivable | $224.5M | $142.0M | $94.8M | $37.7M | — | — | — | — |
| Inventory | $27.9M | $15.7M | $15.1M | $4.3M | — | — | — | — |
| Total Current Assets | $589.0M | $485.1M | $504.3M | $245.6M | $86.5M | $184.0M | $220.4M | $15.2M |
| Property, Plant & Equipment | $562.0K | $584.0K | $846.0K | $722.0K | $283.8K | $52.6K | $30.6K | $51.8K |
| Goodwill | $12.0M | $12.0M | $12.0M | $10.3M | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $40.5M | $46.9M | $53.3M | $59.7M | — | — | — | — |
| Total Assets | $689.8M | $568.5M | $588.2M | $331.5M | $87.8M | $186.1M | $220.5M | $15.4M |
| Liabilities | ||||||||
| Accounts Payable | $65.5M | $72.0M | $40.7M | $38.6M | $13.1M | $13.5M | $10.9M | $3.7M |
| Total Current Liabilities | $378.8M | $230.1M | $138.9M | $96.6M | $23.1M | $23.4M | $24.5M | $10.8M |
| Long-Term Debt | $117.7M | $180.7M | $178.1M | $94.3M | $49.1M | $48.3M | $17.3M | $3.6M |
| Total Liabilities | $601.5M | $511.5M | $397.3M | $221.9M | $72.2M | $72.3M | $41.8M | $14.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.31B | $-1.12B | $-835.6M | $-596.3M | $-409.2M | $-278.8M | $-175.9M | $-107.6M |
| Total Stockholders' Equity | $88.3M | $57.0M | $191.0M | $109.6M | $15.6M | $113.8M | $178.7M | $937.9K |